Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation
about
BMPs and their clinical potentialsPotential roles of BMP9 in liver fibrosisActivin receptor-like kinases: a diverse family playing an important role in cancerBone morphogenetic protein-9 induces osteogenic differentiation of rat dental follicle stem cells in P38 and ERK1/2 MAPK dependent mannerBMP9 is a proliferative and survival factor for human hepatocellular carcinoma cellsEffects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanismThe Yin and Yang of bone morphogenetic proteins in cancer.Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells.BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.The role of the 3'UTR region in the regulation of the ACVR1/Alk-2 gene expression.ALK1 as an emerging target for antiangiogenic therapy of cancerA draft network of ligand-receptor-mediated multicellular signalling in human.Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthBiological roles of human bone morphogenetic protein 9 in the bone microenvironment of human breast cancer MDA-MB-231 cellsEpigenetic Regulation of GDF2 Suppresses Anoikis in Ovarian and Breast Epithelia.The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertensionBone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.BMP signaling and its paradoxical effects in tumorigenesis and dissemination.Ovarian cancer molecular pathology.Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma.Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.Matters of context guide future research in TGFβ superfamily signaling.RUNX1 Plays an Important Role in Mediating BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Line C3H10T1/2, Murine Multi-Lineage Cells Lines C2C12 and MEFs.BMP9-Induced Survival Effect in Liver Tumor Cells Requires p38MAPK Activation.Inactivation of the phosphatidylinositol 3-kinase/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells.Suppression of EGFR-STAT3 signaling inhibits tumorigenesis in a lung cancer cell line.BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression.BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231.MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodiesSmad8/9 Is Regulated Through the BMP Pathway.ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models.Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma.BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1.A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.Effects of general anesthesia with or without epidural block on tumor metastasis and mechanisms.Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
P2860
Q26824827-D5D7C39B-CBC4-400D-9C0E-3E37EE41EB0EQ26998823-4CC2F909-4CD6-4459-9CD4-62540A5DC3DAQ28066886-3CEBC121-8463-462C-8B7A-12E057C8BC91Q28279305-E598C4E2-4F1A-41E5-83AD-63D3E8AA624CQ28296361-80904C8A-4E86-4E42-A1FD-3D62C438A15CQ33850748-0F9FED3F-D73B-492A-B296-1D7847539F04Q34127207-B06A6C57-B6A6-462A-A6CC-95E428810A6DQ34212149-AA53617A-0EBE-49A9-A0B1-AA3EB6700364Q34454218-48E4B611-175D-4E12-8009-8D62B0584313Q34507168-36E400B5-D35D-406B-8C57-7B1650F6AACBQ35127963-4E005BF7-4F7E-4353-99C7-1B996E33DFB7Q35917059-BEA1A530-65B0-4260-BFDC-B2D79B42D5EFQ36011433-E26D5784-413E-40E1-B19D-D628F39C7338Q36225875-E1779C0C-B04F-4326-B14A-537FDC3FB895Q36378875-10C36980-E8AC-43E5-AC09-7DEC6950B119Q36457064-F0334406-F9F7-458E-B054-4A025145EB6CQ37340780-DE59C029-A3B0-4DCD-B6A7-B6EFEE970C57Q37462563-3018D7FF-8809-4EE0-9619-5A6E66EE26FFQ37687466-8E0FA334-A44A-421D-9B89-4801828A2443Q37718513-9B325CDA-6C19-4076-87FC-8D9974FCC6A6Q38021356-C49D0078-49F9-45D6-8383-C271E6BF9266Q38199567-BB41B454-744B-4272-8407-F725F3CFB925Q38332451-393675FA-AF23-48C5-933B-D731E14BC366Q38588911-D3C18C0C-A231-40F9-BF59-83D2E6E0F7FAQ38612468-3C9EE165-38E7-4D3F-A7F2-B39640B80383Q38699239-422E0648-4B2D-491F-834A-E88CBF5B3DB4Q38837502-8C672143-4D70-4F63-90EF-D96CBA0CADACQ38914344-92010F07-585D-48B6-B8EB-C0D6BC168729Q38955418-714740F9-4684-4020-8096-112BF19F2379Q39035249-21CA2B8B-92F1-448D-955C-7B9BB8AA3634Q39479477-83C37EB1-94FF-40CC-8649-6DA769295019Q41982606-80AAF8F7-2C1E-461A-9D49-F2CD250FF558Q42815704-74B8E017-C1BC-47ED-9B2D-224A49E911EEQ47142179-8FD5AF83-7A61-4F34-AFE4-4EF0A7EBF99CQ47271790-698AFB47-E954-463E-9068-6F54FBCC0977Q52593632-A1766402-122B-4ED6-9D65-19DB15C32D39Q54107804-5197E103-4897-49FE-8493-FF1B945DD099Q54535911-64C9837A-5A1E-46BF-835F-219D8DB3FC77Q55012925-100C68F7-B4CB-4A8A-8B65-BEC6740BE4F5Q58703705-F7E2D0F3-4AF5-432C-806E-14B9DC3D2B9C
P2860
Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@ast
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@en
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@nl
type
label
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@ast
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@en
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@nl
prefLabel
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@ast
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@en
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@nl
P2093
P2860
P1433
P1476
Autocrine bone morphogenetic p ...... rian cancer cell proliferation
@en
P2093
Blanca Herrera
Gareth J Inman
Maarten van Dinther
Peter Ten Dijke
P2860
P304
P356
10.1158/0008-5472.CAN-09-2912
P407
P577
2009-12-15T00:00:00Z